Amgen 1st-quarter profit boosted by drug price rises, lower R&D
April 21, 2015 at 16:24 PM EDT
April 21 (Reuters) - Amgen Inc reported higher first-quarter earnings on Tuesday, driven by price increases for its biggest-selling drugs, as well as lower spending on research and development.